Trial Profile
A Phase 1, Open-label, Nonrandomized, Single Dose Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]-LX4211, Following Oral Administration, in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Jun 2013
Price :
$35
*
At a glance
- Drugs Sotagliflozin (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 01 May 2013 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 29 Mar 2013 New trial record